About Duchenne UK

Website
Website
Employees
Employees
11-50 employees View all
Industry
Industry
Non-profit Organization Management
Location
Location
Shepherd’s Building,Charecroft Way,London,GB
Description
Information
Duchenne UK is an ambitious and highly focused charity with a clear vision: to fund and accelerate effective treatments for Duchenne muscular dystrophy (DMD). Duchenne muscular dystrophy is a devastating muscle wasting disease and is the most common genetic killer of children worldwide. In the UK there are around 2,500 people affected and around 300,000 worldwide. It is usually diagnosed between the ages of 3 - 6 and mainly affects boys. Children with DMD gradually lose muscle strength and mobility, and have a limited life-expectancy. But thanks to recent breakthroughs, we believe we can save them. We are advancing and accelerating medical research, as well as supporting families affected by the disease and ensuring they receive the best possible care.

Duchenne UK Alternatives

Industry
non-profit organization management
Industry
Non-profit Organization Management
Industry
Non-profit Organization Management
Industry
Non-profit Organization Management
Industry
Non-profit Organization Management
Industry
Non-profit Organization Management

Frequently Asked Questions about Duchenne UK

What is Duchenne UK email format?

The widely used Duchenne UK email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.


What is Duchenne UK customer service number?

To contact Duchenne UK customer service number in your country click here to find.


Who is the CEO of Duchenne UK?

Emily Reuben is the CEO of Duchenne UK. To contact Emily Reuben email at [email protected].


Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more